Invasive breast cancer version 1.2016

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. PierceElizabeth C. Reed, Kilian E. Salerno, Lee Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar

Research output: Contribution to journalReview article

164 Citations (Scopus)

Abstract

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

Original languageEnglish (US)
Pages (from-to)324-354
Number of pages31
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Breast Neoplasms
Guidelines
Neoplasms
Body Regions
Biological Therapy
Therapeutics
Cause of Death
Lung Neoplasms
Radiotherapy
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., ... Kumar, R. (2016). Invasive breast cancer version 1.2016. JNCCN Journal of the National Comprehensive Cancer Network, 14(3), 324-354. https://doi.org/10.6004/jnccn.2016.0037

Invasive breast cancer version 1.2016. / Gradishar, William J.; Anderson, Benjamin O.; Balassanian, Ron; Blair, Sarah L.; Burstein, Harold J.; Cyr, Amy; Elias, Anthony D.; Farrar, William B.; Forero, Andres; Giordano, Sharon Hermes; Goetz, Matthew; Goldstein, Lori J.; Hudis, Clifford A.; Isakoff, Steven J.; Kelly Marcom, P.; Mayer, Ingrid A.; McCormick, Beryl; Moran, Meena; Patel, Sameer A.; Pierce, Lori J.; Reed, Elizabeth C.; Salerno, Kilian E.; Schwartzberg, Lee; Smith, Karen Lisa; Smith, Mary Lou; Soliman, Hatem; Somlo, George; Telli, Melinda; Ward, John H.; Shead, Dorothy A.; Kumar, Rashmi.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, No. 3, 01.03.2016, p. 324-354.

Research output: Contribution to journalReview article

Gradishar, WJ, Anderson, BO, Balassanian, R, Blair, SL, Burstein, HJ, Cyr, A, Elias, AD, Farrar, WB, Forero, A, Giordano, SH, Goetz, M, Goldstein, LJ, Hudis, CA, Isakoff, SJ, Kelly Marcom, P, Mayer, IA, McCormick, B, Moran, M, Patel, SA, Pierce, LJ, Reed, EC, Salerno, KE, Schwartzberg, L, Smith, KL, Smith, ML, Soliman, H, Somlo, G, Telli, M, Ward, JH, Shead, DA & Kumar, R 2016, 'Invasive breast cancer version 1.2016', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 3, pp. 324-354. https://doi.org/10.6004/jnccn.2016.0037
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A et al. Invasive breast cancer version 1.2016. JNCCN Journal of the National Comprehensive Cancer Network. 2016 Mar 1;14(3):324-354. https://doi.org/10.6004/jnccn.2016.0037
Gradishar, William J. ; Anderson, Benjamin O. ; Balassanian, Ron ; Blair, Sarah L. ; Burstein, Harold J. ; Cyr, Amy ; Elias, Anthony D. ; Farrar, William B. ; Forero, Andres ; Giordano, Sharon Hermes ; Goetz, Matthew ; Goldstein, Lori J. ; Hudis, Clifford A. ; Isakoff, Steven J. ; Kelly Marcom, P. ; Mayer, Ingrid A. ; McCormick, Beryl ; Moran, Meena ; Patel, Sameer A. ; Pierce, Lori J. ; Reed, Elizabeth C. ; Salerno, Kilian E. ; Schwartzberg, Lee ; Smith, Karen Lisa ; Smith, Mary Lou ; Soliman, Hatem ; Somlo, George ; Telli, Melinda ; Ward, John H. ; Shead, Dorothy A. ; Kumar, Rashmi. / Invasive breast cancer version 1.2016. In: JNCCN Journal of the National Comprehensive Cancer Network. 2016 ; Vol. 14, No. 3. pp. 324-354.
@article{9d91c2f5b5ac484d96b33898f71d50c8,
title = "Invasive breast cancer version 1.2016",
abstract = "Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.",
author = "Gradishar, {William J.} and Anderson, {Benjamin O.} and Ron Balassanian and Blair, {Sarah L.} and Burstein, {Harold J.} and Amy Cyr and Elias, {Anthony D.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Matthew Goetz and Goldstein, {Lori J.} and Hudis, {Clifford A.} and Isakoff, {Steven J.} and {Kelly Marcom}, P. and Mayer, {Ingrid A.} and Beryl McCormick and Meena Moran and Patel, {Sameer A.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Salerno, {Kilian E.} and Lee Schwartzberg and Smith, {Karen Lisa} and Smith, {Mary Lou} and Hatem Soliman and George Somlo and Melinda Telli and Ward, {John H.} and Shead, {Dorothy A.} and Rashmi Kumar",
year = "2016",
month = "3",
day = "1",
doi = "10.6004/jnccn.2016.0037",
language = "English (US)",
volume = "14",
pages = "324--354",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "3",

}

TY - JOUR

T1 - Invasive breast cancer version 1.2016

AU - Gradishar, William J.

AU - Anderson, Benjamin O.

AU - Balassanian, Ron

AU - Blair, Sarah L.

AU - Burstein, Harold J.

AU - Cyr, Amy

AU - Elias, Anthony D.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goetz, Matthew

AU - Goldstein, Lori J.

AU - Hudis, Clifford A.

AU - Isakoff, Steven J.

AU - Kelly Marcom, P.

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Moran, Meena

AU - Patel, Sameer A.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Salerno, Kilian E.

AU - Schwartzberg, Lee

AU - Smith, Karen Lisa

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Somlo, George

AU - Telli, Melinda

AU - Ward, John H.

AU - Shead, Dorothy A.

AU - Kumar, Rashmi

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

AB - Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

UR - http://www.scopus.com/inward/record.url?scp=84961577176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961577176&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2016.0037

DO - 10.6004/jnccn.2016.0037

M3 - Review article

C2 - 26957618

AN - SCOPUS:84961577176

VL - 14

SP - 324

EP - 354

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 3

ER -